Security Snapshot

Astrana Health, Inc. - Common Stock (ASTH) Institutional Ownership

CUSIP: 03763A207

13F Institutional Holders and Ownership History from Q4 2017 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

174

Shares (Excl. Options)

29,137,341

Price

$24.81

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
ASTH on Nasdaq
Shares outstanding
50,156,118
Price per share
$24.52
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
29,137,341
Total reported value
$724,380,671
% of total 13F portfolios
0%
Share change
+2,612,013
Value change
+$62,743,872
Number of holders
174
Price from insider filings
$24.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • ASTH - Astrana Health, Inc. - Common Stock is tracked under CUSIP 03763A207.
  • 174 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 174 to 56 between Q4 2025 and Q1 2026.
  • Reported value moved from $724,380,671 to $115,530,737.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 174 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 03763A207?
CUSIP 03763A207 identifies ASTH - Astrana Health, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Astrana Health, Inc. - Common Stock (ASTH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% +9.1% $191,646,870 -$6,109,882 6,234,446 -3.1% BlackRock, Inc. 31 Mar 2025
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 11% -10% $188,522,333 -$21,514,803 6,132,802 -10% Allied Physicians of California, a Professional Medical Corporation 15 Feb 2025

As of 31 Dec 2025, 174 institutional investors reported holding 29,137,341 shares of Astrana Health, Inc. - Common Stock (ASTH). This represents 58% of the company’s total 50,156,118 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Astrana Health, Inc. - Common Stock (ASTH) together control 49% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 6,157,754 +2.5% 0% $152,773,879
VANGUARD GROUP INC 8.5% 4,238,192 -10% 0% $105,149,543
325 CAPITAL LLC 3.7% 1,839,076 +54% 16% $45,627,476
STATE STREET CORP 3.3% 1,675,516 +6.2% 0% $41,569,552
DIMENSIONAL FUND ADVISORS LP 2.4% 1,215,812 -1.5% 0.01% $30,164,897
FMR LLC 2.1% 1,069,809 -0.55% 0% $26,541,963
GEODE CAPITAL MANAGEMENT, LLC 2% 1,028,168 +1.2% 0% $25,513,406
WELLINGTON MANAGEMENT GROUP LLP 1.5% 738,853 +418% 0% $18,330,943
SteelPeak Wealth, LLC 1.2% 579,937 0% 0.47% $14,388,237
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 549,152 -2.3% 0% $13,624,461
BANK OF AMERICA CORP /DE/ 1% 507,101 +193% 0% $12,581,176
JACOBS LEVY EQUITY MANAGEMENT, INC 0.94% 473,714 -5.4% 0.05% $11,752,844
NorthCrest Asset Manangement, LLC 0.9% 450,465 +0.46% 0.28% $12,342,741
AMERIPRISE FINANCIAL INC 0.87% 437,996 -0.98% 0% $10,866,681
MORGAN STANLEY 0.86% 433,825 -13% 0% $10,763,199
DIAMOND HILL CAPITAL MANAGEMENT INC 0.86% 432,726 +20% 0.06% $10,735,932
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.83% 416,930 -1.1% 0.03% $10,344,033
NORTHERN TRUST CORP 0.8% 402,463 -4.9% 0% $9,985,107
Invesco Ltd. 0.71% 355,216 +46% 0% $8,812,908
ROYCE & ASSOCIATES LP 0.69% 348,331 +34% 0.09% $8,642,092
GOLDMAN SACHS GROUP INC 0.63% 314,691 -0.73% 0% $7,807,484
LPL Financial LLC 0.62% 309,125 +74% 0% $7,669,391
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.61% 305,061 +74124% 0.01% $7,568,000
PRINCIPAL FINANCIAL GROUP INC 0.46% 229,798 +3.1% 0% $5,701,289
Bank of New York Mellon Corp 0.46% 229,664 -6.4% 0% $5,697,970

Institutional Holders of Astrana Health, Inc. - Common Stock (ASTH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 4,711,777 $115,530,737 -$3,139,847 $24.52 56
2025 Q4 29,137,341 $724,380,671 +$62,743,872 $24.81 174
2025 Q3 26,741,841 $759,043,836 +$22,746,916 $28.35 186
2025 Q2 25,772,189 $641,392,329 -$15,342,979 $24.88 161
2025 Q1 26,257,633 $814,637,036 +$5,862,823 $31.01 168
2024 Q4 26,057,927 $822,017,819 +$3,128,832 $31.53 177
2024 Q3 25,295,709 $1,465,673,353 +$131,700,353 $57.94 186
2024 Q2 23,072,576 $935,815,210 +$22,763,995 $40.56 169
2024 Q1 22,756,494 $955,393,465 +$24,413,741 $41.99 158
2023 Q4 22,178,838 $849,210,903 +$26,256,665 $38.30 141
2023 Q3 21,503,159 $663,623,547 +$22,662,738 $30.85 132
2023 Q2 20,757,071 $656,229,537 +$22,212,849 $31.60 129
2023 Q1 20,034,782 $730,631,066 +$14,461,853 $36.47 131
2022 Q4 19,704,382 $583,144,207 -$13,404,604 $29.59 129
2022 Q3 19,814,272 $772,607,625 +$70,014,740 $39.00 148
2022 Q2 17,767,757 $685,808,256 +$18,274,263 $38.59 126
2022 Q1 17,609,470 $853,298,644 +$10,418,988 $48.47 129
2021 Q4 17,108,614 $1,256,730,970 +$26,349,379 $73.48 140
2021 Q3 16,644,270 $1,516,521,911 +$595,571,146 $91.05 137
2021 Q2 10,256,705 $644,299,364 +$260,959,544 $62.81 102
2021 Q1 6,359,542 $172,275,211 +$32,027,527 $27.09 75
2020 Q4 5,211,206 $95,222,607 +$2,906,278 $18.27 60
2020 Q3 5,058,422 $90,682,749 +$15,496,005 $17.94 62
2020 Q2 4,195,952 $69,229,389 +$12,105,432 $16.50 49
2020 Q1 3,507,141 $45,315,795 -$1,124,491 $12.92 49
2019 Q4 3,560,356 $65,544,872 -$36,902,879 $18.41 54
2019 Q3 5,569,591 $98,135,067 +$47,954,977 $17.62 46
2019 Q2 2,846,110 $47,557,190 +$8,339,757 $16.71 36
2019 Q1 2,387,347 $43,737,062 -$549,177 $18.33 37
2018 Q4 2,407,330 $47,779,685 +$851,599 $19.85 39
2018 Q3 2,283,686 $50,402,877 -$7,479,217 $22.07 36
2018 Q2 2,611,128 $67,524,947 +$58,395,475 $25.86 32
2018 Q1 541,971 $8,644,000 +$7,424,160 $15.95 13
2017 Q4 50,403 $1,209,000 +$1,209,000 $23.97 6
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .